For instance, the fibrinogen β chain, retinol-binding protein 4 (RBP4), serum amyloid P component, lumican, transgelin 2, and CD5 antigen-like exhibit differential levels of expression among patient groups and present a global success rate of 76%, whereas complement component C7, the insulin-like growth factor acid labile subunit, and transgelin 2 present a global success rate of 90% wherein they are characterized by simple steatosis and NASH and are able to accurately differentiate between control subjects and patients with all forms of NAFLD [62]. The gene discussed is LUM; the disease is metabolic dysfunction-associated steatohepatitis.